MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxias(SCA)"

  • 2017 International Congress

    Movement Disorders and Clinical Progression in Spinocerebellar Ataxias

    P.-H. Kuo, J. Wang, K. Figueroa, S. Pulst, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, S. Subramony, T. Ashizawa, S.-H. Kuo (Hualien, Taiwan)

    Objective: To study the prevalence and influence of movement disorder signs in SCAs. Background: Movement disorders are common features in spinocerebellar ataxias (SCAs) but their…
  • 2017 International Congress

    Living with Ataxia in Ireland 2016–a nationwide survey of 130 Irish patients with inherited Ataxia

    P. Bogdanova-Mihaylova, R. Walsh, S. Murphy (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort of patients with inherited ataxia in Ireland, with special attention to the individual ataxia-related healthcare resources…
  • 2017 International Congress

    Corticospinal tract dysfunction precede the cerebellar syndrome in spinocerebellar ataxia 2

    R. Rodríguez-Labrada, L. Velázquez-Pérez, R. Torres-Vega, J. Medrano-Montero, Y. Vázquez-Mojena, G. Auburger, U. Ziemann (Holguín, Cuba)

    Objective: To evaluate if corticospinal tract (CST) dysfunction appears before the cerebellar syndrome in SCA2 Background: Studies of corticospinal tract (CST) function in prodromal spinocerebellar…
  • 2017 International Congress

    Allelic CACNA1A disorders: a retrospective cohort analysis on clinical course and overlapping features

    W. Nachbauer, P. Dorin, E. Indelicato, A. Eigentler, S. Boesch (Innsbruck, Austria)

    Objective: To (1) retrospectively study emerging clinical symptoms and disease course in a cohort of patients with genetically proven CACNA1A mutations and (2) to define…
  • 2016 International Congress

    Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)

    A. Zanatta, A.C.d.S. Crippa, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)

    Objective: The aim of this study was to assess the frequency of abnormal findings in sleep recordings of patients with SCA2. Background: Similar to other…
  • 2016 International Congress

    Cancer in Machado Joseph disease patients – Low frequency as a cause of death

    L.B. Jardim, G.N. Souza, N. Kersting, T.A. Gonçalves, D. Pacheco, M.L. Saraiva-Pereira, J.A. Saute (Porto Alegre, Brazil)

    Objective: To compare the 15 years cumulative incidence of cancer (CIC) and the proportion of cancer as a cause of death in symptomatic Spinocerebellar ataxia…
  • 2016 International Congress

    CAG repeats number of ATXN7 in SCA7 patients and normal population in Japan

    Y. Adachi, R. Shimoyama (Matsue, Japan)

    Objective: Patients with spinocerebellar ataxia type 7 (SCA7) have progressive ataxia associated with pigmental macular degeneration, pyramidal and extrapyramidal signs and some of them have…
  • 2016 International Congress

    The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3

    T. Schmidt, A. Sowa, I.M. Martins, M. Abedi, Z. Wang, J. Schmidt, H. Tricoire, O. Riess (Tübingen, Germany)

    Objective: Spinocerebellar ataxia type 3 (SCA3) or Machado-Joseph disease (MJD) is a neurodegenerative disorder caused by a CAG expansion in the MJD1 gene leading to…
  • 2016 International Congress

    Clinical and imaging characteristics of spinocerebellar ataxia type 14 defined in a German multi-center sample

    T. Schmitz-Hübsch, S. Lux, A.U. Brandt, P. Bauer, E. Schlapakow, S. Greschus, H. Gärtner, M.E. Kirlangic, V. Gras, D. Timmann, M. Synofzik, N. Shah, L. Schöls, U. Kopp, T. Oberwahrenbrock, H. Zimmermann, C. Pfueller, E.M. Kadas, M. Rönnefarth, A. Grosch, M. Endres, T. Klockgether, K. Amunts, F. Paul, S. Doss, M. Minnerop (Berlin, Germany)

    Objective: To give a concise description of clinical and imaging features of spinocerebellar ataxia type 14 (SCA14). Background: Since its genetic definition in 2003, the…
  • 2016 International Congress

    Huntington disease phenocopies or misdiagnosis: A black South African cohort

    F.K. Baine, A. Krause (Johannesburg, South Africa)

    Objective: To investigate the occurrence of phenocopy mutations in a cohort of black South African individuals referred to the National Health Laboratory Service (NHLS) for…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley